Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Jp, Levesque"'
Publikováno v:
Blood. 82:800-806
The effect of human fibrinogen on the proliferation of purified SBA- CD34+ human bone marrow progenitors was investigated in clonal cultures. Fibrinogen alone or in combination with erythropoietin had no significant effect. However, in the presence o
Autor:
Sm, Watt, Lh, Butler, Tavian M, Hj, Bühring, Rappold I, Pj, Simmons, Ac, Zannettino, Buck D, Fuchs A, Regis Doyonnas, Jy, Chan, Jp, Levesque, Peault B, Roxanis I
Publikováno v:
Europe PubMed Central
Three distinct classes of epitopes on human CD164 have been identified. Two of these, recognized by the monoclonal antibodies 105A5 and 103B2/9E10, are the CD164 class I and class II functionally defined epitopes, which cooperate to regulate adhesion
Autor:
Wei Y; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Forelli RF; Real-time Processing Systems Division, Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA.; Department of Electrical and Computer Engineering, Lehigh University, Bethlehem, Pennsylvania 18015, USA., Hansen C; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Levesque JP; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Tran N; Real-time Processing Systems Division, Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA.; Department of Electrical and Computer Engineering, Northwestern University, Evanston, Illinois 60208, USA., Agar JC; Department of Mechanical Engineering and Mechanics, Drexel University, Philadelphia, Pennsylvania 19104, USA., Di Guglielmo G; Department of Electrical and Computer Engineering, Northwestern University, Evanston, Illinois 60208, USA.; Microelectronics Division, Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA., Mauel ME; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Navratil GA; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA.
Publikováno v:
The Review of scientific instruments [Rev Sci Instrum] 2024 Jul 01; Vol. 95 (7).
Autor:
Li B; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Levesque JP; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Wei Y; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Saperstein A; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Chandra RN; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Navratil GA; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Mauel ME; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA., Hansen C; Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA.
Publikováno v:
The Review of scientific instruments [Rev Sci Instrum] 2023 Oct 01; Vol. 94 (10).
Autor:
Tay J; Mater Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Bisht K; Mater Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Winkler IG; Mater Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Levesque JP; Mater Research Institute, The University of Queensland, Woolloongabba, QLD, Australia. jp.levesque@mater.uq.edu.au.; Translational Research Institute, Woolloongabba, QLD, Australia. jp.levesque@mater.uq.edu.au.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2635, pp. 43-61.
Autor:
Millard SM; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Heng O; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Opperman KS; Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace, Adelaide, SA 5005, Australia; South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA 5001, Australia., Sehgal A; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Irvine KM; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Kaur S; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia; The University of Queensland, UQ Diamantina Institute, Brisbane, QLD 4102, Australia., Sandrock CJ; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Wu AC; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia; TRI Flow Cytometry Suite, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Magor GW; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia., Batoon L; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Perkins AC; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia., Noll JE; Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace, Adelaide, SA 5005, Australia; South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA 5001, Australia., Zannettino ACW; Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace, Adelaide, SA 5005, Australia; South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA 5001, Australia; Central Adelaide Local Health Network, Adelaide, SA 5001, Australia., Sester DP; TRI Flow Cytometry Suite, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Levesque JP; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Hume DA; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Raggatt LJ; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Summers KM; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Pettit AR; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia. Electronic address: allison.pettit@mater.uq.edu.au.
Publikováno v:
Cell reports [Cell Rep] 2021 Nov 23; Vol. 37 (8), pp. 110058.
Autor:
Tay J; Stem Cell and Cancer Group, Blood and Bone Diseases Program, Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Barbier V; Stem Cell and Cancer Group, Blood and Bone Diseases Program, Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Helwani FM; Stem Cell Biology Group, Blood and Bone Diseases Program, Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Price GR; Stem Cell and Cancer Group, Blood and Bone Diseases Program, Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Levesque JP; Stem Cell Biology Group, Blood and Bone Diseases Program, Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia., Winkler IG; Stem Cell and Cancer Group, Blood and Bone Diseases Program, Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
Publikováno v:
Stem cells (Dayton, Ohio) [Stem Cells] 2021 Nov; Vol. 39 (11), pp. 1532-1545.
Autor:
Debaud C; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.; Spine Division, Orthopaedic Surgery Department, Queensland Health, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Université de Versailles Saint Quentin en Yvelines, U1179 INSERM, UFR des Sciences de la Santé-Simone Veil, Montigny-le-Bretonneux, France.; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Saint Lucia, Queensland, Australia., Tseng HW; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Chedik M; Université de Versailles Saint Quentin en Yvelines, U1179 INSERM, UFR des Sciences de la Santé-Simone Veil, Montigny-le-Bretonneux, France., Kulina I; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Genêt F; Université de Versailles Saint Quentin en Yvelines, U1179 INSERM, UFR des Sciences de la Santé-Simone Veil, Montigny-le-Bretonneux, France.; Service de Réhabilitation, Hôpital Raymond Poincaré, APHP, CIC-IT 1429, Garches, France., Ruitenberg MJ; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Saint Lucia, Queensland, Australia., Levesque JP; Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Publikováno v:
Journal of neurotrauma [J Neurotrauma] 2021 Aug 01; Vol. 38 (15), pp. 2162-2175. Date of Electronic Publication: 2021 Jun 18.
Autor:
Davies JM; Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Radford KJ; Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Begun J; Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Levesque JP; Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia., Winkler IG; Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia.
Publikováno v:
Immunology and cell biology [Immunol Cell Biol] 2021 Jul; Vol. 99 (6), pp. 622-639. Date of Electronic Publication: 2021 Mar 09.
Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.
Autor:
Starobova H; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Monteleone M; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Adolphe C; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Batoon L; Mater Research Institute and Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia.; Translational Research Institute, Woolloongabba, Queensland, Australia., Sandrock CJ; Mater Research Institute and Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia.; Translational Research Institute, Woolloongabba, Queensland, Australia., Tay B; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Deuis JR; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Smith AV; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Mueller A; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Nadar EI; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Lawrence GP; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Mayor A; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Tolson E; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Levesque JP; Mater Research Institute and Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia.; Translational Research Institute, Woolloongabba, Queensland, Australia., Pettit AR; Mater Research Institute and Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia.; Translational Research Institute, Woolloongabba, Queensland, Australia., Wainwright BJ; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Schroder K; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia., Vetter I; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.; The School of Pharmacy, The University of Queensland, Woolloongabba, Queensland, Australia.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2021 May 03; Vol. 218 (5).